Achieve Life Sciences to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 12, 2021

SEATTLE, Wash. and VANCOUVER, British Columbia / ACCESSWIRE / August 3, 2021 / Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that it will report its second quarter 2021 financial results and provide an update on the cytisinicline development program on Thursday, August 12, 2021 at 4:30PM EDT.

To access the webcast, log on to the Investor Relations page of the Achieve website at Alternatively, you may access the live conference call by dialing (877) 472-9809 (U.S. & Canada) or (629) 228-0791 (International) and referencing conference ID 8694398. A webcast replay will be available approximately two hours after the call and will be archived on the website for 90 days.

Investor Relations Contact 
Jason Wong
[email protected]
(415) 375-3340 ext. 4

Media Contact
Glenn Silver
[email protected]
(646) 871-8485